Maui Business

Pain Management with Medical Cannabis, May 18

Play
Listen to this Article
1 minute
Loading Audio... Article will play after ad...
Playing in :00
A
A
A

Michael Backes

Medical cannabis researcher and author, Michael Backes returns to Maui for another Lunch & Learn presentation from 1 to 3 p.m. on Saturday, May 18, at the Leis Family Class Act Restaurant, on the second floor of the Pāʻina Building at the University of Hawaiʻi Maui College campus in Kahului.

Organizers say Backes will share the latest research on cannabinoids and pain management and how medical cannabis is helping patients to reduce dependence on prescription opiates.

A $20 registration fee includes a hot lunch buffet and class materials.

ARTICLE CONTINUES BELOW AD
ARTICLE CONTINUES BELOW AD

In 2017, the National Academies of Sciences, Engineering and Medicine reviewed more than 10,000 scientific abstracts to reach its nearly 100 conclusions, including evidence that cannabis is an effective treatment for chronic pain in adults. Backes will explain how and why cannabis helps to manage pain.

Michael Backes is the author of Cannabis Pharmacy: The Practical Guide to Medical Marijuana, an inside look at the most effective varieties of cannabis for specific conditions. He currently serves as Curriculum and Training advisor for Maui Grown Therapies in Kahului and is a member of their Science and Medical Advisory Board.

Event Sponsor, CertiCann, aims to simplify the process of getting a Hawaiʻi Medical Cannabis (329) Card.  Maui Grown Therapies is a physician-led, patient-centered team of medical doctors, scientists, researchers, medical cannabis experts and Maui business leaders.

ADVERTISEMENT
ADVERTISEMENT

Sponsored Content

Subscribe to our Newsletter

Stay in-the-know with daily or weekly
headlines delivered straight to your inbox.
Cancel
×

Comments

This comments section is a public community forum for the purpose of free expression. Although Maui Now encourages respectful communication only, some content may be considered offensive. Please view at your own discretion. View Comments